Insider Transactions in Q2 2024 at Arcutis Biotherapeutics, Inc. (ARQT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Bhaskar Chaudhuri Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+1.16%
|
-
|
|
Jun 14
2024
|
Halley E Gilbert Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 14
2024
|
Sue Jean Lin Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+34.65%
|
-
|
|
Jun 14
2024
|
Neha Krishnamohan Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+39.17%
|
-
|
|
Jun 14
2024
|
Terrie Curran Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 14
2024
|
Patrick J Heron Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 14
2024
|
Howard G. Welgus Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+5.32%
|
-
|
|
Jun 14
2024
|
Keith R Leonard Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,139
+35.0%
|
-
|
|
Jun 04
2024
|
Howard G. Welgus Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.81%
|
$80,000
$8.01 P/Share
|
|
Jun 04
2024
|
Howard G. Welgus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.73%
|
$10,000
$1.68 P/Share
|
|
May 31
2024
|
Todd Franklin Watanabe Director |
BUY
Open market or private purchase
|
Direct |
4,000
+0.48%
|
$4,000
$1.69 P/Share
|
|
May 31
2024
|
Masaru Matsuda Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+2.11%
|
$4,000
$1.69 P/Share
|
|
May 30
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
23,000
-9.88%
|
$184,000
$8.75 P/Share
|
|
May 30
2024
|
Patrick Burnett Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,000
+8.99%
|
-
|
|
May 29
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
49,952
-19.23%
|
$399,616
$8.72 P/Share
|
|
May 28
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
1,775
-0.93%
|
$15,975
$9.01 P/Share
|
|
May 27
2024
|
Masaru Matsuda Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,875
+2.5%
|
-
|
|
May 17
2024
|
Larry Todd Edwards Officer |
SELL
Open market or private sale
|
Direct |
7,640
-5.16%
|
$61,120
$8.98 P/Share
|
|
May 16
2024
|
Larry Todd Edwards Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+28.85%
|
-
|
|
May 02
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,681
-3.12%
|
$37,448
$8.74 P/Share
|
|
May 02
2024
|
Patrick Burnett Officer |
SELL
Open market or private sale
|
Direct |
9,555
-3.55%
|
$76,440
$8.74 P/Share
|
|
May 02
2024
|
Masaru Matsuda Officer |
SELL
Open market or private sale
|
Direct |
5,016
-2.63%
|
$40,128
$8.74 P/Share
|
|
May 02
2024
|
Todd Franklin Watanabe Director |
SELL
Open market or private sale
|
Direct |
13,783
-1.58%
|
$110,264
$8.74 P/Share
|
|
May 01
2024
|
Matthew Richard Moore SVP and Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,166
+2.7%
|
-
|
|
Apr 10
2024
|
David Joseph Topper Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+50.0%
|
-
|